Editor’s note: Bankruptcies are listed in chronological order.
- Florida drugmaker files for bankruptcy after recall
KRS Global Biotechnology, a Boca Raton, Fla.-based drug-compounding facility, filed for Chapter 11 bankruptcy, citing “unforeseen business circumstances.” - Insys bankruptcy plan gets court OK
Insys Therapeutics, the first drugmaker to go bankrupt after opioid litigation, won court approval for its bankruptcy plan Jan. 16. - Reva Medical files for bankruptcy
Reva Medical, a San Diego-based devicemaker that specializes in vascular devices, has filed for Chapter 11 bankruptcy, listing $5.9 million in assets and $104.5 million in debt. - Insulin pump maker files for bankruptcy
Valeritas Holdings, a New Jersey-based company that makes insulin pumps, filed for Chapter 11 bankruptcy, and Zealand Pharma, a Denmark-based drugmaker, said it will acquire “substantially all” of Valeritas’ assets. - Mallinckrodt to put US generics business in bankruptcy in opioid settlement
Mallinckrodt filed for Chapter 11 bankruptcy for its generic drug business as part of a settlement with 47 U.S. states and U.S. territories. - Generic drugmaker Akorn files for bankruptcy
Akorn, a generic drugmaker based in Lake Forest, Ill., has filed for Chapter 11 bankruptcy a year after the FDA sent it warning letters about manufacturing violations at two of its plants.
More articles on pharmacy:
Generic remdesivir to cost up to $79 per dose
GlaxoSmithKline recalls 2 cough syrups with wrong dosing cups
CVS partners with American Lung Association for COVID-19 research effort
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
